Background The vasoconstrictor terlipressin is used for type 1 hepatorenal syndrome (HRS-1)
in many parts of the world and is part of the clinical practice guidelines in Europe. …

Chinese translation Background: Telaprevir (TVR) plus peginterferon-α2a (PEG-IFN-α2a) and
ribavirin substantially increases treatment efficacy for genotype 1 chronic hepatitis C virus (…

Background & Aims Caspase-mediated apoptosis and inflammation contribute to progression
of liver disease. Emricasan is a pan-caspase inhibitor that reduced serum markers of …

PURPOSE: To perform a retrospective evaluation of transjugular intrahepatic portosystemic
shunt (TIPS) placement for treatment of intestinal varices. MATERIALS AND METHODS: …

Background and Aims Organs from hepatitis C virus (HCV)‐viremic donors have been used
in HCV‐uninfected recipients (D+/R‐), but the optimal treatment approach has not been …

Objectives: To determine which clinical characteristics are associated with decreased
survival after transjugular intrahepatic portosystemic shunting (TIPS). Methods: Forty-nine …

Purpose: To explain the rationale supporting the use of ursodiol (ursodeoxycholic acid) for
the treatment of patients with cholesterol gallstones and chronic liver diseases and to …

Hepatic masses come to clinical attention when they are perceived by the patient, discovered
on physical examination by the physician, or, most commonly, detected on diagnostic …

Anorectal varices are portal-systemic collaterals commonly found in patients with portal
hypertension. Although these varices rarely bleed, when bleeding does occur it may be massive …

BACKGROUND & AIMS: Noncirrhotic portal hypertension (NCPH) is unusual in North
American patients. This study characterized patients with NCPH and human immunodeficiency …